Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

CMV infection increases the risk of GvHD after bone marrow transplants.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

Most children with MIS-C showed significant improvement by 6 months.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.